These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 4360862

  • 1. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract] [Full Text] [Related]

  • 2. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF, Ceglowski WS, Friedman H.
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G, Holden HT, Herberman RB.
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [Abstract] [Full Text] [Related]

  • 4. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT, Kirchner H, Herberman RB.
    J Immunol; 1975 Aug; 115(2):327-31. PubMed ID: 168259
    [Abstract] [Full Text] [Related]

  • 5. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M.
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract] [Full Text] [Related]

  • 6. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC, Senik A, Gomard E, Plata F, Levy JP.
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B.
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract] [Full Text] [Related]

  • 8. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT, Röllinghoff M, Warner NL.
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract] [Full Text] [Related]

  • 9. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G, Lennox ES.
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract] [Full Text] [Related]

  • 10. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 11. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
    Eggers AE, Wunderlich JR.
    J Immunol; 1975 May; 114(5):1554-6. PubMed ID: 123545
    [Abstract] [Full Text] [Related]

  • 12. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM.
    J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract] [Full Text] [Related]

  • 13. Phagocytic cells as effectors in a cell-mediated immunity system.
    Dennert G, Lennox ES.
    J Immunol; 1973 Dec; 111(6):1844-54. PubMed ID: 4543031
    [No Abstract] [Full Text] [Related]

  • 14. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR, Cerottini JC, Brunner KT.
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract] [Full Text] [Related]

  • 15. [In vitro induction of cell-mediated cytotoxicity].
    Lohmann-Matthes M-L.
    Allerg Immunol (Leipz); 1973 Dec; 19(2-4):297-302. PubMed ID: 4281631
    [No Abstract] [Full Text] [Related]

  • 16. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W, Cohen EP.
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract] [Full Text] [Related]

  • 17. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM.
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J, Bonavida B, Fahey JL.
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract] [Full Text] [Related]

  • 19. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract] [Full Text] [Related]

  • 20. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms.
    Gardner I, Bowern NA, Blanden RV.
    Eur J Immunol; 1974 Feb; 4(2):68-72. PubMed ID: 4546746
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.